Jasmine davda (9 risultati)

Autore: 
Perfeziona con la Ricerca avanzata

Perfeziona la tua ricerca

  • Libri (9)

  • Nuovo (9)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: LAP Lambert Academic Publishing 2009-08-26, 2009

    3838309707 / 9783838309705

    • Brossura

    Da: Chiron Media, Wallingford, Regno UnitoChiron Media

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 45,14

    EUR 18,07 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 10 disponibili

    Paperback. Condizione: New.

  • Lingua: Inglese

    Editore: LAP Lambert Academic Publishing, 2009

    3838309707 / 9783838309705

    • Brossura

    Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 52,63

    EUR 10,93 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New. In English.

  • Altre immagini

    Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2010

    3838309707 / 9783838309705

    • Brossura

    Da: preigu, Osnabrück, Germaniapreigu

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 43,40

    EUR 70,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 5 disponibili

    Taschenbuch. Condizione: Neu. Physiologically Based Pharmacokinetic Modeling | Of Monoclonal Antibodies | Jasmine Davda | Taschenbuch | 112 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838309705 | Verantwortliche Person für die EU: OmniScriptum GmbH & Co. KG, Bahnhofstr. 28, 66111 Saarbrücken, info[at]akademikerverlag[dot]de | Anbieter: preigu. …

  • Lingua: Inglese

    Editore: LAP Lambert Academic Publishing, 2009

    3838309707 / 9783838309705

    • Brossura
    • Print on Demand

    Da: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 52,54

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    PAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Lingua: Inglese

    Editore: LAP Lambert Academic Publishing, 2009

    3838309707 / 9783838309705

    • Brossura
    • Print on Demand

    Da: PBShop.store UK, Fairford, GLOS, Regno UnitoPBShop.store UK

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 49,94

    EUR 4,85 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: Più di 20 disponibili

    PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing Mai 2010, 2010

    3838309707 / 9783838309705

    • Brossura
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 49,00

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book describes the application of physiologically based pharmacokinetic (PBPK) modeling to characterize the disposition of therapeutic monoclonal antibodies (MAbs). These macromolecules exhibit distinctly different pharmacokinetic features compared with conventional small-molecule drugs. A PBPK model was developed to characterize the biodistribution of the pancarcinoma MAb CC49 in normal and neoplastic tissues of nude mice. The model included all the major processes involved in determining the disposition characteristics of MAbs. The applicability of the model was tested by predicting the disposition of di- and tetravalent scFv constructs of CC49 in mice. Further, the model was applied to study the differences in disposition between Mabs labeled with 125I and 177Lu. Finally, the clinical utility of the model was tested by attempting to predict the disposition and tumor uptake of CC49 in patients. This model may be used to study the biodistribution and tumor localization of different combinations of radionuclides and engineered antibody fragments in an effort to establish the most effective approach to achieve the optimal therapeutic ratio for tumor therapy. 112 pp. Englisch.…

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2009

    3838309707 / 9783838309705

    • Brossura
    • Print on Demand

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 51,71

    EUR 35,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibile

    Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book describes the application of physiologically based pharmacokinetic (PBPK) modeling to characterize the disposition of therapeutic monoclonal antibodies (MAbs). These macromolecules exhibit distinctly different pharmacokinetic features compared with conventional small-molecule drugs. A PBPK model was developed to characterize the biodistribution of the pancarcinoma MAb CC49 in normal and neoplastic tissues of nude mice. The model included all the major processes involved in determining the disposition characteristics of MAbs. The applicability of the model was tested by predicting the disposition of di- and tetravalent scFv constructs of CC49 in mice. Further, the model was applied to study the differences in disposition between Mabs labeled with 125I and 177Lu. Finally, the clinical utility of the model was tested by attempting to predict the disposition and tumor uptake of CC49 in patients. This model may be used to study the biodistribution and tumor localization of different combinations of radionuclides and engineered antibody fragments in an effort to establish the most effective approach to achieve the optimal therapeutic ratio for tumor therapy.…

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2010

    3838309707 / 9783838309705

    • Brossura
    • Print on Demand

    Da: moluna, Greven, Germaniamoluna

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 41,05

    EUR 48,99 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Davda JasmineJasmine Davda received her MS and Ph.D. in Pharmaceutical Sciences from the University of Nebraska in 2000 and 2007, respectively. Between 2001 and 2004, Dr. Davda was Research Scientist at Piramal Life Sciences, Indi. …

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing Mai 2010, 2010

    3838309707 / 9783838309705

    • Brossura
    • Print on Demand

    Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 49,00

    EUR 60,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibile

    Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book describes the application of physiologically based pharmacokinetic (PBPK) modeling to characterize the disposition of therapeutic monoclonal antibodies (MAbs). These macromolecules exhibit distinctly different pharmacokinetic features compared with conventional small-molecule drugs. A PBPK model was developed to characterize the biodistribution of the pancarcinoma MAb CC49 in normal and neoplastic tissues of nude mice. The model included all the major processes involved in determining the disposition characteristics of MAbs. The applicability of the model was tested by predicting the disposition of di- and tetravalent scFv constructs of CC49 in mice. Further, the model was applied to study the differences in disposition between Mabs labeled with 125I and 177Lu. Finally, the clinical utility of the model was tested by attempting to predict the disposition and tumor uptake of CC49 in patients. This model may be used to study the biodistribution and tumor localization of different combinations of radionuclides and engineered antibody fragments in an effort to establish the most effective approach to achieve the optimal therapeutic ratio for tumor therapy.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 112 pp. Englisch.…